Status:
COMPLETED
Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab
Lead Sponsor:
Federico II University
Conditions:
Coats Disease
Eligibility:
MALE
19-30 years
Brief Summary
This study evaluates the retinal and vascular features in patients affected by Coats disease under the effects of Ranibizumab intravitreal injections using optical coherence tomography and optical coh...
Detailed Description
Coats disease is an idiopathic retinal vascular disorder, occurs in young males, and is characterized by retinal telangiactasias, numerous yellowish exudates in the subretinal space, macular edema, he...
Eligibility Criteria
Inclusion
- age older than 18 years
- diagnosis of Coats disease
- treatment-naïve with Ranibizumab
- absence of other vitreoretinal and vascular retinal diseases
- absence of diabetes
Exclusion
- age younger than 18 years
- No diagnosis of Coats disease
- previous treatments with Ranibizumab
- presence of vitreoretinal and vascular retinal diseases
- presence of diabetes
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04310631
Start Date
January 1 2016
End Date
December 31 2019
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Naples "Federico II"
Naples, Italy, 80100